The Reprocessed CS Diagnostic EP Catheter is indicated for electrophysiological mapping of cardiac structures; i.e., stimulation and recording only. The catheter is designed for use in the coronary sinus.

Device Description

The Reprocessed CS Diagnostic Electrophysiology Catheter is a steerable, multi-electrode catheter with a deflectable tip designed to facilitate electrophysiological mapping of the heart. The device is a 7FR catheter with a usable length of 115 cm. The catheter has a high-torque shaft with a braided deflectable, Bi-Directional tip section containing platinum electrodes that can be used for recording and stimulation. Two curve types, D/F and F/J, for CS placement, are available. Specific to Reprocessed CS Diagnostic Electrophysiology Catheters with Auto ID Technology: Each catheter is equipped with EEPROM (Electronically Erasable Programmable Read Only Memory), which is used to save unique catheter identification information. CARTO® EP Navigation Systems equipped with Auto ID Technology can access the saved information and automatically recognize the catheter information. This device has been cleared for three (3) reprocessing cycles.

AI/ML Overview

This document is a 510(k) premarket notification for a repurposed medical device, specifically a "Reprocessed CS Diagnostic Electrophysiology Catheter." It is NOT describing an AI/ML powered device, therefore, the information requested about acceptance criteria, study details, sample sizes, ground truth, and expert involvement for an AI/ML device is not applicable.

The document primarily focuses on establishing substantial equivalence to existing predicate devices based on modifications to the "Instructions for Use" by adding contraindications. It does not contain any performance studies or data comparing the reprocessed device's performance against specific acceptance criteria in the manner an AI/ML device would be evaluated.

Therefore, I cannot provide the requested information.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

January 24, 2019

Stryker Sustainability Solutions Mia McCorkel Regulatory Affairs Specialist 1810 W. Drake Drive Tempe, Arizona 85283

Re: K181056

Trade/Device Name: Reprocessed CS Diagnostic Electrophysiology Catheter Regulation Number: 21 CFR 870.1220 Regulation Name: Electrode Recording Catheter or Electrode Recording Probe Regulatory Class: Class II Product Code: NLH Dated: December 21, 2018 Received: December 26, 2018

Dear Mia McCorkel:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice

(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely

Mada Jellman
for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Model Number	Description
BD710DF282RTS	Bi-Directional Catheter, 7F, DF Curve, 115 cm useable length, 2 mm tip electrode
BD710FJ282RTS	Bi-Directional Catheter, 7F, FJ Curve, 115 cm useable length, 2 mm tip electrode
BD710DF282CT	Bi-Directional Catheter with Auto ID Technology, 7F, DF Curve, 115 cm useable length, 2 mm tip electrode
BD710FJ282CT	Bi-Directional Catheter with Auto ID Technology, 7F, FJ Curve, 115 cm useable length, 2 mm tip electrode

The following device models are included in the scope of this 510(k) submission:

{3}------------------------------------------------

Indications for Use

510(k) Number (if known) K181056

Device Name

Reprocessed CS Diagnostic Electrophysiology Catheter

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

Change Being Effected – Addition of Contraindication

510(k) Summary

SUBMITTER:

Stryker Sustainability Solutions 1810 W. Drake Drive Tempe, Arizona 85283

CONTACT:

Mia McCorkel Regulatory Affairs Specialist 480-343-1855 (o) 480-763-5310 (f) mia.mccorkel@stryker.com Date of Preparation: January 24, 2019

NAME OF DEVICE:

Trade/Proprietary Name:	Reprocessed CS Diagnostic Electrophysiology Catheter
Model Numbers:	BD710DF282RTS, BD710DF282CT, BD710FJ282RTS, BD710FJ282CT
Common Name:	Electrode recording catheter or electrode recording probe
Classification Information:	Cardiovascular, Reprocessed (21 CFR §870.1220, Product Code NLH,Class II)

{5}------------------------------------------------

PREDICATE DEVICES:

510(k) Number	510(k) Title	Original Manufacturer
K100254	Reprocessed CS Bi-Directional DiagnosticElectrophysiology Catheter	Stryker SustainabilitySolutions
K090898	Coronary Sinus Deflectable MappingCatheters, Webster CS Catheter with EZSteer Technology, Webster CS Catheter withEZ Steer Technology and Auto ID	Biosense Webster, Inc.
K101345	Webster CS Catheter with EZ SteerTechnology, Webster CS Catheter with EZSteer Technology an Auto ID	Biosense Webster, Inc.

DEVICE DESCRIPTION:

Specific to Reprocessed CS Diagnostic Electrophysiology Catheters with Auto ID Technology: Each catheter is equipped with EEPROM (Electronically Erasable Programmable Read Only Memory), which is used to save unique catheter identification information. CARTO® EP Navigation Systems equipped with Auto ID Technology can access the saved information and automatically recognize the catheter information.

This device has been cleared for three (3) reprocessing cycles.

INTENDED USE:

{6}------------------------------------------------

COMPARISON WITH THE PREDICATE DEVICE:

The only modification made was to the Instructions for Use. The following contraindications were added.

Use of the catheter is contraindicated in patients with totally obstructed Coronary Sinus.
The catheter should not be used in patients unable to receive heparin or an acceptable alternative to achieve the adequate anticoagulation.
. Electrophysiology studies are contraindicated when reversible factors make the findings unrepresentative of the patient's disease state (e.g. electrolyte imbalance).

DEVICE MODEL NUMBERS:

Original Manufacturer	Model Number	Description
Biosense Webster	BD710DF282RTS	Reprocessed CS Diagnostic Electrophysiology Catheter, 7F, DF Curve, 115 cm useable length, 2 mm tip electrode
Biosense Webster	BD710FJ282RTS	Reprocessed CS Diagnostic Electrophysiology Catheter, 7F, FJ Curve, 115 cm useable length, 2 mm tip electrode
Biosense Webster	BD710DF282CT	Reprocessed CS Diagnostic Electrophysiology Catheter with Auto ID Technology, 7F, DF Curve, 115 cm useable length, 2 mm tip electrode
Biosense Webster	BD710FJ282CT	Reprocessed CS Diagnostic Electrophysiology Catheter with Auto ID Technology, 7F, FJ Curve, 115 cm useable length, 2 mm tip electrode

CONCLUSION:

The Reprocessed CS Diagnostic Electrophysiology Catheters are safe, effective, and substantially equivalent to the predicate devices as described herein. The only modification made was to the Instructions for Use as described.

Regulation Number and Section

§ 870.1220 Electrode recording catheter or electrode recording probe.

(a)
Identification. An electrode recording catheter or an electrode recording probe is a device used to detect an intracardiac electrocardiogram, or to detect cardiac output or left-to-right heart shunts. The device may be unipolar or multipolar for electrocardiogram detection, or may be a platinum-tipped catheter which senses the presence of a special indicator for cardiac output or left-to-right heart shunt determinations.(b)
Classification. Class II (performance standards).